People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,464.50GBp
12:08pm EDT
Change (% chg)

14.00p (+0.96%)
Prev Close
1,450.50p
Open
1,452.00p
Day's High
1,473.50p
Day's Low
1,447.00p
Volume
7,385,452
Avg. Vol
8,918,698
52-wk High
1,658.39p
52-wk Low
1,296.50p

Search Stocks

Dingemans, Simon 

Mr. Simon Dingemans is Chief Financial Officer, Executive Director of GlaxoSmithKline plc. Prior to joining GSK, Simon has over 25 years of experience in investment banking at SG Warburg and Goldman Sachs. During this time, he advised a broad range of large corporates across a number of industry sectors, including pharmaceuticals and consumer healthcare. Simon advised GSK for over a decade before his appointment and was closely involved in a number of GSK’s key strategic projects. Simon is Chairman of the 100 Group and a member of the Corporate Development Council for the National Theatre.

Basic Compensation

Total Annual Compensation, GBP 1,243,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 607,000
Fiscal Year Total, GBP 1,850,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Philip Hampton

--

Andrew Witty

3,891,000

Simon Dingemans

1,850,000

Moncef Slaoui

4,333,000

Roger Connor

--

Shah Abbas Hussain

--
As Of  30 Dec 2014
Search Stocks